Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

NADA M ELBULUK

Allopathic & Osteopathic Physicians Dermatology

NPI
1013146307
CMS profile
819047
Location
LOS ANGELES, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

General Payments · PY2025

$92,340.43

36 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Data mirrored . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · sorted by reported total

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $28,270.00 9
ABBVIE INC. $24,282.08 11
Eli Lilly and Company $20,341.96 6
Takeda Pharmaceuticals U.S.A., Inc. $11,898.00 4
Incyte Corporation $7,062.50 4
Janssen Scientific Affairs, LLC $485.89 2

Payment records · PY2025 (36)

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
PFIZER INC. $5,400.00 12/24/2025 Consulting Fee No dispute reported 06/30/2026 1229398495 CMS
Incyte Corporation $3,062.50 12/18/2025 Consulting Fee No dispute reported 06/30/2026 1226021795 CMS
Eli Lilly and Company $141.96 12/17/2025 Travel and Lodging No dispute reported 06/30/2026 1186763610 CMS
ABBVIE INC. $4,750.00 12/15/2025 Consulting Fee No dispute reported 06/30/2026 1201810377 CMS
Eli Lilly and Company $4,000.00 12/15/2025 Consulting Fee No dispute reported 06/30/2026 1186765362 CMS
Eli Lilly and Company $2,800.00 12/15/2025 Consulting Fee No dispute reported 06/30/2026 1186788345 CMS
Takeda Pharmaceuticals U.S.A., Inc. $5,187.00 11/21/2025 Consulting Fee No dispute reported 06/30/2026 1223793605 CMS
PFIZER INC. $2,250.00 09/25/2025 Consulting Fee No dispute reported 06/30/2026 1229132037 CMS
Eli Lilly and Company $8,200.00 09/23/2025 Consulting Fee No dispute reported 06/30/2026 1186847037 CMS
ABBVIE INC. $950.00 09/17/2025 Consulting Fee No dispute reported 06/30/2026 1201810375 CMS
Takeda Pharmaceuticals U.S.A., Inc. $798.00 09/04/2025 Consulting Fee No dispute reported 06/30/2026 1223793281 CMS
PFIZER INC. $2,700.00 09/02/2025 Consulting Fee No dispute reported 06/30/2026 1229167054 CMS
ABBVIE INC. $5,700.00 08/26/2025 Consulting Fee No dispute reported 06/30/2026 1201810371 CMS
ABBVIE INC. $2,375.00 08/26/2025 Consulting Fee No dispute reported 06/30/2026 1201810373 CMS
Incyte Corporation $1,600.00 08/05/2025 Consulting Fee No dispute reported 06/30/2026 1226034763 CMS
Eli Lilly and Company $1,200.00 07/21/2025 Consulting Fee No dispute reported 06/30/2026 1186847035 CMS
Janssen Scientific Affairs, LLC $35.89 07/11/2025 Food and Beverage No dispute reported 06/30/2026 1174151509 CMS
PFIZER INC. $2,250.00 07/08/2025 Consulting Fee No dispute reported 06/30/2026 1231600565 CMS
Janssen Scientific Affairs, LLC $450.00 05/08/2025 Consulting Fee No dispute reported 06/30/2026 1174205551 CMS
PFIZER INC. $2,250.00 05/02/2025 Consulting Fee No dispute reported 06/30/2026 1229681775 CMS
ABBVIE INC. $3,087.50 04/18/2025 Consulting Fee No dispute reported 06/30/2026 1201810365 CMS
ABBVIE INC. $6,650.00 04/18/2025 Consulting Fee No dispute reported 06/30/2026 1201810367 CMS
ABBVIE INC. $109.24 04/18/2025 Travel and Lodging No dispute reported 06/30/2026 1201810369 CMS
Takeda Pharmaceuticals U.S.A., Inc. $4,788.00 04/02/2025 Consulting Fee No dispute reported 06/30/2026 1223793587 CMS
PFIZER INC. $1,800.00 03/31/2025 Consulting Fee No dispute reported 06/30/2026 1231219827 CMS
ABBVIE INC. $23.24 03/27/2025 Food and Beverage No dispute reported 06/30/2026 1201810357 CMS
ABBVIE INC. $549.10 03/27/2025 Travel and Lodging No dispute reported 06/30/2026 1201810359 CMS
ABBVIE INC. $64.76 03/27/2025 Food and Beverage No dispute reported 06/30/2026 1201810361 CMS
ABBVIE INC. $23.24 03/27/2025 Food and Beverage No dispute reported 06/30/2026 1201810363 CMS
PFIZER INC. $1,800.00 03/20/2025 Consulting Fee No dispute reported 06/30/2026 1231553384 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,125.00 02/11/2025 Consulting Fee No dispute reported 06/30/2026 1223793333 CMS
Incyte Corporation $800.00 01/17/2025 Consulting Fee No dispute reported 06/30/2026 1226057752 CMS
PFIZER INC. $2,700.00 01/16/2025 Consulting Fee No dispute reported 06/30/2026 1231115978 CMS
Eli Lilly and Company $4,000.00 01/14/2025 Consulting Fee No dispute reported 06/30/2026 1186765364 CMS
Incyte Corporation $1,600.00 01/09/2025 Consulting Fee No dispute reported 06/30/2026 1226134926 CMS
PFIZER INC. $7,120.00 01/07/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported 06/30/2026 1231119325 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $1,335.00 1
PY2021 $12,491.33 5
PY2022 $40,989.49 18
PY2023 $55,207.26 39
PY2024 $94,231.21 51
PY2025 $92,340.43 36

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
NADA M ELBULUK, NPI 1013146307. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1013146307.
APA 7
IndustryPayments. (2026). NADA M ELBULUK, NPI 1013146307 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1013146307
Bluebook
NADA M ELBULUK, NPI 1013146307, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1013146307.

Source: Centers for Medicare & Medicaid Services, Open Payments.